Why regulating nitrosamines in India will prove challenging

Unlike the US drug regulator, however, the Indian drug regulator, CDSCO, does not yet require the pharma industry to control for nitrosamines. This means that firms that supply to the Indian market are currently left to their own devices

from mint - Science https://ift.tt/3jX9z1J
https://ift.tt/eA8V8J